NEW YORK (360Dx) – Singulex announced today that it has applied the CE mark to its ultra-sensitive troponin I assay, the Sgx Clarity cTnl Assay.

The assay quantitatively measures the biomarker troponin at far lower levels than existing technologies, and is indicated for use on the single molecule counting-based Sgx Clarity platform for in vitro diagnostics, the company said. The assay is meant to be used in conjunction with clinical evaluation for ruling out cardiac ischemia in patients suspected of having coronary artery disease.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.